Insider Selling: Trupanion (NASDAQ:TRUP) CEO Sells 491 Shares of Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 491 shares of the business’s stock in a transaction on Monday, May 25th. The shares were sold at an average price of $21.86, for a total transaction of $10,733.26. Following the transaction, the chief executive officer owned 176,379 shares in the company, valued at $3,855,644.94. This trade represents a 0.28% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Trupanion Trading Down 0.8%

TRUP stock traded down $0.17 during mid-day trading on Wednesday, reaching $21.69. 371,901 shares of the stock traded hands, compared to its average volume of 428,641. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.73 and a current ratio of 1.73. Trupanion, Inc. has a one year low of $21.16 and a one year high of $57.88. The stock has a market capitalization of $946.12 million, a PE ratio of 36.76 and a beta of 1.49. The business has a 50-day moving average price of $25.08 and a two-hundred day moving average price of $30.52.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The business had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. During the same quarter in the previous year, the business posted ($0.03) earnings per share. The business’s revenue was up 12.3% compared to the same quarter last year. Equities research analysts expect that Trupanion, Inc. will post 0.53 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada lifted its stake in Trupanion by 60.6% in the first quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after acquiring an additional 11,233 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Trupanion by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock worth $731,000 after acquiring an additional 858 shares during the period. Millennium Management LLC lifted its stake in Trupanion by 73.5% in the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock worth $9,987,000 after acquiring an additional 113,490 shares during the period. Invesco Ltd. lifted its stake in Trupanion by 35.1% in the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock worth $10,392,000 after acquiring an additional 48,781 shares during the period. Finally, Gabelli Funds LLC purchased a new stake in Trupanion in the second quarter worth about $249,000.

Wall Street Analyst Weigh In

A number of research firms have recently commented on TRUP. Bank of America cut their price target on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Cantor Fitzgerald cut their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a report on Thursday, April 9th. Piper Sandler cut their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Finally, Stifel Nicolaus cut their price target on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, March 31st. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $42.25.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.